Private And Government Fundings Promote The Interventional Oncology Devices Market Growth

Private And Government Fundings Promote The Interventional Oncology Devices Market Growth

Interventional Oncology Devices Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

The Business Research Company’s Interventional Oncology Devices Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

LONDON, GREATER LONDON, UK, May 6, 2022 /EINPresswire.com/ — The availability of private and government funding drove the interventional oncology devices market growth. In the field of cancer, funding from the government and private has increased, especially for the devices used in treatments as it promotes early detection and better survival rates. The American Cancer Society, the largest non-government, not-for-profit cancer research funder, has awarded 93 grants which totaled $40 million in the first of two cycles for 2019 for cancer research. BioProtect Ltd, an Israeli company that develops novel bioabsorbable polymer spacer balloons, received a funding of $13 million of its Series D equity financing from a leading global syndicate of venture investors that finances the ongoing multicenter FDA clinical trial of BioProtect’s lead product, the ProSpace balloon spacer, which protects prostate cancer patients undergoing radiation therapy. Endosight, the first augmented-reality-guided ablative system, has received 20% of its funding from private organizations. According to the interventional oncology devices market analysis, the funding from government and private organizations helps in the development of new technologies and devices, thereby driving the market.

The global interventional oncology devices market size is expected to grow from $1.97 billion in 2021 to $2.15 billion in 2022 at a compound annual growth rate (CAGR) of 9.4%. The global interventional oncology device market is expected to grow to $3.03 billion in 2026 at a CAGR of 8.9%.

Read more on the Global Interventional Oncology Devices Market Report
https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Interventional oncology devices market overview shows that companies are focusing on deploying robotics technology in interventional oncology devices, for higher efficiency. The robotic system integrates image-based planning and navigation with the installation of different instruments to the desired body part with better accuracy and efficiency.

Major players covered in the global interventional oncology devices industry are Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Merit Medical Systems Inc, Philips Volcano, AngioDynamics Inc, GE Healthcare, Siemens Healthineers, Sirtex Medical, and Cook Medical Incorporated.

TBRC’s global interventional oncology devices market report is segmented by product into embolization devices, ablation devices, support devices, by procedure into thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization (TACE), transcatheter arterial radioembolization (TARE) or selective internal radiation therapy (SIRT), transcatheter arterial embolization (TAE) or bland embolization, by cancer type into liver cancer, kidney cancer, lung cancer, bone cancer, others.

Interventional Oncology Devices Global Market Report 2022 – By Product (Embolization Devices, Ablation Devices, Support Devices), By Procedure (Thermal Tumor Ablation, Non-thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE) or Bland Embolization), By Cancer Type (Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types) – Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides a interventional oncology devices market overview, forecast interventional oncology devices market size and growth for the whole market, interventional oncology devices market segments, geographies, interventional oncology devices market trends, interventional oncology devices market drivers, interventional oncology devices market restraints, leading competitors’ revenues, profiles, and interventional oncology devices market shares.

Request for a Sample of the Global Interventional Oncology Devices Market Report
https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp

Not what you were looking for? Here is a list of similar reports by The Business Research Company:
Oncology Devices Global Market Report 2022 – By Device Type (Brachytherapy Devices, Endoscopic Devices), By Therapy (Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radiation Therapy), By End User (Hospitals, Cancer Research Institutes) – Market Size, Trends, And Global Forecast 2022-2026
https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Oncology Drugs Global Market Report 2022 – By Type (Lung Cancer Drugs, Pancreatic Cancer Drugs, Breast Cancer Drugs, Prostate Cancer Drugs, Ovarian Cancer Drugs, Colorectal Cancer Drugs, Gastric Cancer Drugs, Kidney Cancer Drugs, Brain Tumor Drugs, Thyroid Cancer Drugs, Skin Cancer Drugs, Bladder Cancer Drugs, Cervical Cancer Drugs, Blood Cancer Drugs, Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026
https://www.thebusinessresearchcompany.com/report/oncology-drugs-global-market-report

Oncology Molecular Diagnostics Global Market Report 2022 – By Product (Instruments, Reagents), By Technology (Polymerase Chain Reaction (PCR), In-Situ Hybridization (ISH), Isothermic Nucleic Acid Amplification Technology (INNAT), Chips & Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification (TMA)), By End User (Hospitals, Diagnostic Centers, Academic & Research Institutes) – Market Size, Trends, And Global Forecast 2022-2026
https://www.thebusinessresearchcompany.com/report/oncology-molecular-diagnostics-global-market-report

About The Business Research Company?

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Check out our:
LinkedIn: https://bit.ly/3b7850r
Twitter: https://bit.ly/3b1rmjS
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn

Market Research Products, Services, Solutions For Your Business – TBRC

Article originally published at https://www.einpresswire.com/article/571354047/private-and-government-fundings-promote-the-interventional-oncology-devices-market-growth

Global News - Social Gov originally published at Global News - Social Gov

WATCH: SpaceX launches first private astronaut mission to the ISS Previous post WATCH: SpaceX launches first private astronaut mission to the ISS
FAA Approves Airworthiness Criteria for Wingcopter Next post FAA Approves Airworthiness Criteria for Wingcopter